FOR IMMEDIATE RELEASE
April 18, 2002
NIMH Press Office
NIMH Awards New Grants
In Response to Terrorist Attacks of September 11, 2001
- David Vlahov, Ph.D., and Gerry Fairbrother, Ph.D., at the New York Academy of Medicine, to conduct surveys of the New York metropolitan area to determine what effects the 9/11 attacks have had on symptoms, mental disorders and use of mental health services.
- Rose Zimering, Ph.D., at Boston University, to assess post-traumatic stress disorder (PTSD) in clinicians who treated survivors of the attacks.
- Cynthia Pfeffer, M.D., at Cornell University/New York Presbyterian Hospital, to examine whether major acute stress from the death of a child's parent is associated with increased activity in stress hormones, symptoms of psychiatric disability, and physical growth.
- Charles Marmar, M.D., at San Francisco VA Medical Center, to compare the effects of brief cognitive behavioral therapy to the usual treatment for New York City disaster relief workers with full or sub-threshold PTSD diagnoses related to the World Trade Center (WTC) terrorist attacks.
In addition, NIMH has awarded six supplemental grants to existing studies so that the investigators can gather new information specific to the 9/11 events.
Supplemental grants have been awarded to:
- Hector Bird, M.D., at New York Psychiatric Institute, who is conducting a longitudinal study of mental health of Hispanic boys and girls and their caregivers, will use the supplemental grant to focus on levels of child and caregiver symptoms of depression, PTSD, and other anxiety disorders, before and after the 9/11 events; changes in patterns of service use and expressed need for services.
- Edna Foa, Ph.D., and Rachel Yehuda, Ph.D., at the University of Pennsylvania and Mount Sinai School of Medicine, who are involved in a collaborative study of the effects of different treatments on PTSD symptoms in patients with chronic PTSD. The supplement will help to understand differences in psychobiology between chronic cases of PTSD and those occurring in the immediate aftermath of a trauma.
- Joseph LeDoux, Ph.D., at New York University, who has been studying how stress can trigger mental disorders, will conduct neuroimaging studies of changes in the brain following the WTC terrorist attacks. This research is expected to generate new tools for testing people with anxiety/fear-related disorders, providing windows into more effective prevention and treatment.
- Daphne Simeon, M.D., at Mt Sinai School of Medicine, will include survivors of the WTC attacks in an ongoing New York-based study of psychobiological factors thought to determine whether trauma exposure results in PTSD or a dissociative disorder. Findings are expected to improve understanding of neurobiological malfunction resulting from traumatic stress and help to design different types of prevention, early intervention, and long-term treatment.
- Joann Difede, Ph.D., at New York Presbyterian Hospital, is studying an intervention to prevent chronic PTSD in adult burn patients, many of whom were rescued from the WTC on 9/11. The supplement will enable Difede's team to expand their research to include most survivors of the WTC attacks.
- Jerrold Rosenbaum, M.D., at Massachusetts General Hospital and Harvard Medical School, Boston, who is studying children at risk for anxiety disorders based on a range of individual vulnerability and environmental factors, will select a sub-sample from this group to study the effects of various degrees of exposure to the 9/11 events.
NIMH supports a number of national health and mental health surveys that will provide a snapshot of mental health in the U.S. before and after the 9/11 terrorist acts, including information about the associations between exposure to the attacks and levels of overall distress and function, mental disorder onset or recurrence, medication use, substance use, and need and use of mental health services. Results of these benchmark surveys will aid in developing future studies that explore the causes and treatment of stress-related mental disorders. In addition, researchers will be able to test hypotheses generated from case-control studies within these larger, representative samples.
NIMH is part of the National Institutes of Health (NIH), the Federal Government's primary agency for biomedical and behavioral research. NIH is a component of the U.S. Department of Health and Human Services.